Yep, revenue is lower than expected. Cash burn to staff continues to be very high. Capital raise inevitable. I'm moving on elsewhere.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025